Department of Geriatric Medicine and Aging Research, University of Zurich, Zurich 8037, Switzerland.
Centre on Aging and Mobility, University of Zurich, Zurich 8037, Switzerland.
J Bone Miner Res. 2024 Jul 23;39(6):661-671. doi: 10.1093/jbmr/zjae054.
Evidence on the effects of Vitamin D, omega-3s, and exercise on areal bone mineral density (aBMD) in healthy older adults is limited. We examined whether vitamin D3, omega-3s, or a simple home-based exercise program (SHEP), alone or in combination, over 3 years, improve lumbar spine (LS), femoral neck (FN), or total hip (TH) aBMD assessed by DXA. Areal BMD was a secondary outcome in DO-HEALTH, a 3-year, multicenter, double-blind, randomized 2 × 2 × 2 factorial design trial in generally healthy older adults age ≥ 70 years. The study interventions were vitamin D3 (2000IU/d), omega-3s (1 g/d), and SHEP (3 × 30 min/wk), applied alone or in combination in eight treatment arms. Mixed effects models were used, adjusting for age, sex, BMI, prior fall, study site, and baseline level of the outcome. Main effects were assessed in the absence of an interaction between the interventions. Subgroup analyses by age, sex, physical activity level, dietary calcium intake, serum 25(OH)D levels, and fracture history were conducted. DXA scans were available for 1493 participants (mean age 75 years; 80.4% were physically active, 44% had 25(OH)D levels <20 ng/mL). At the LS and FN sites, none of the treatments showed a benefit. At the TH, vitamin D versus no vitamin D treatment showed a significant benefit across 3 years (difference in adjusted means [AM]: 0.0035 [95% CI, 0.0011, 0.0059] g/cm). Furthermore, there was a benefit for vitamin D versus no vitamin D treatment on LS aBMD in the male subgroup (interaction P = .003; ∆AM: 0.0070 [95% CI, 0.0007, 0.0132] g/cm). Omega-3s and SHEP had no benefit on aBMD in healthy, active, and largely vitamin D replete older adults. Our study suggests a small benefit of 2000 IU vitamin D daily on TH aBMD overall and LS aBMD among men; however, effect sizes were very modest and the clinical impact of these findings is unclear.
关于维生素 D、欧米伽 3 和运动对健康老年人骨矿物质密度(aBMD)的影响的证据有限。我们研究了维生素 D3、欧米伽 3 或简单的家庭运动计划(SHEP)单独或联合使用 3 年是否能改善腰椎(LS)、股骨颈(FN)或总髋部(TH)的 aBMD,通过 DXA 评估。骨矿物质密度是 DO-HEALTH 的次要结果,这是一项为期 3 年、多中心、双盲、随机 2×2×2 析因设计试验,纳入了年龄≥70 岁的一般健康老年人。研究干预措施为维生素 D3(2000IU/d)、欧米伽 3(1g/d)和 SHEP(每周 3 次,每次 30 分钟),单独或联合应用于 8 个治疗组。使用混合效应模型,根据年龄、性别、BMI、既往跌倒、研究地点和结局的基线水平进行调整。在没有干预措施相互作用的情况下评估主要效果。根据年龄、性别、体力活动水平、膳食钙摄入量、血清 25(OH)D 水平和骨折史进行亚组分析。共有 1493 名参与者(平均年龄 75 岁;80.4%的人活跃,44%的人 25(OH)D 水平<20ng/ml)进行了 DXA 扫描。在 LS 和 FN 部位,没有一种治疗方法显示出益处。在 TH 部位,与不服用维生素 D 相比,服用维生素 D 治疗 3 年后有显著获益(调整后平均差值[AM]:0.0035[95%CI,0.0011,0.0059]g/cm)。此外,在男性亚组中,与不服用维生素 D 相比,服用维生素 D 对 LS aBMD 也有获益(交互 P=0.003;AM 差值:0.0070[95%CI,0.0007,0.0132]g/cm)。在健康、活跃且维生素 D 充足的老年人中,欧米伽 3 和 SHEP 对骨矿物质密度没有益处。我们的研究表明,每天服用 2000IU 维生素 D 对总体 TH aBMD 和男性 LS aBMD 有较小的益处;然而,这些发现的效果大小非常小,其临床意义尚不清楚。